[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment Benefit with Omalizumab in Children by Indicators of Asthma Severity.
Szefler SJ, Casale TB, Haselkorn T, Yoo B, Ortiz B, Kattan M, Busse WW. Szefler SJ, et al. Among authors: casale tb. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2673-2680.e3. doi: 10.1016/j.jaip.2020.03.033. Epub 2020 Apr 13. J Allergy Clin Immunol Pract. 2020. PMID: 32298853 Free article.
First do no harm: managing antihistamine impairment in patients with allergic rhinitis.
Casale TB, Blaiss MS, Gelfand E, Gilmore T, Harvey PD, Hindmarch I, Simons FE, Spangler DL, Szefler SJ, Terndrup TE, Waldman SA, Weiler J, Wong DF; Antihistamine Impairment Roundtable. Casale TB, et al. J Allergy Clin Immunol. 2003 May;111(5):S835-42. doi: 10.1067/mai.2003.1550. J Allergy Clin Immunol. 2003. PMID: 12743547 Review.
Omalizumab in asthma: approval and postapproval experience.
Chiang DT, Clark J, Casale TB. Chiang DT, et al. Among authors: casale tb. Clin Rev Allergy Immunol. 2005 Aug;29(1):3-16. doi: 10.1385/CRIAI:29:1:003. Clin Rev Allergy Immunol. 2005. PMID: 16222080 Review.
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Deniz Y; Immune Tolerance Network Group. Casale TB, et al. J Allergy Clin Immunol. 2006 Jan;117(1):134-40. doi: 10.1016/j.jaci.2005.09.036. Epub 2005 Dec 2. J Allergy Clin Immunol. 2006. PMID: 16387596 Clinical Trial.
400 results